Pharmaceutical Technology\'s In the Lab eNewsletter-09-05-2018

September 05, 2018

Considering the challenging nature of performing glycan analysis, what are the benefits of outsourcing glycan analysis for sponsor companies?

August 30, 2018

To ensure the safety and efficacy of biologic drug products, the materials that come in contact with the drug must be fully characterized to determine their impact.

August 29, 2018

Flush solutions for liquid chromatography mass spectrometry (LC-MS) systems and ultrapure solvents for ultra-high-performance LC-MS systems from Thermo Fisher Scientific can minimize interference and maximize lab instrument uptime.

August 29, 2018

Shimadzu’s Imagereveal MS mass spectrometry imaging data analysis software can analyze large sets of data or simultaneously analyze multiple sets of data.

August 29, 2018

The acquisition strengthens Nelson Labs’ outsourced testing capabilities for the pharmaceutical and medical device industries.

August 29, 2018

Protagen Protein Services, a CRO, now offers quicker and more accurate characterization of biomolecular stability using differential scanning calorimetry (DSC).

August 29, 2018

PDA Technical Report 80 (TR 80): Data Integrity in Laboratory Systems is the first in a series of three technical reports PDA will publish on data integrity.

August 29, 2018

The TSQ Fortis Triple Quadrupole Mass Spectrometer from Thermo Fisher Scientific offers fast, robust liquid chromatography-mass spectrometry (LC-MS/MS) analysis for clinical research laboratories.

August 29, 2018

The Lumis electron backscatter diffraction (EBSD) detector incorporates a large-format complementary metal oxide semiconductor (CMOS) sensor to enable higher sample throughput, higher resolution measurements, and precise phase identification.

August 29, 2018

The company’s new electron microscopy and microanalysis solutions offer scientists enhanced research capabilities.

August 16, 2018

The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.

August 09, 2018

The combined companies will provide research- and clinical-grade human immune cells, blood products, and related services.

August 08, 2018

Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.

August 01, 2018

The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.